Filter results

Eating Disorders Symptoms clinical trials

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

View clinical trials related to Eating Disorders Symptoms.

Filter by:

Completed
Page 1

NCT ID: NCT02624713 Completed - Clinical trials for Eating Disorders Symptoms

Development of Eating Disorders Symptoms Among Children

Start date: November 2015
Phase: N/A
Study type: Interventional

Randomized Clinical Trial, the research will be composed of two parts in order to examine the research question: a combination of controlled randomized retrospective research and prospective cohort research Prospective Cohort Research: The research groups - families coming for treatment in "Active Maccabi" clinics in the Northern Region, Israel. Approximately 30 families. Retrospective Random Controlled Research 1. The research group - families that have completed an intervention program of "Active Maccabi" Northern Region, Israel,within the past two to three years. The families will be requested to attend a follow-up meeting of all family members in which they will answer questionnaires. Approximately 66 families. 2. The control groups - families who did not participate in the program who have a child between the age 7-14 who has suffered from obesity/weight (over the past 2-3 years), in correlation with the child in the intervention group. Approximately 66 families. Hypotheses of the research: 1. Status of the weight of the child being treated and of his siblings will be higher than that at the end of the program. 2. Indication of the obesogenic environment of families participating in the program will be lower in comparison with families not participating in the program. 3. The rate of eating disorder symptoms among children who participated in the program will be lower in comparison with those of the obese/overweight child in families who were not the program. 4. The rate of eating disorder symptoms among siblings who participated in the program will be lower than that of siblings in families not in the program.